Proteomic signatures in laryngeal squamous cell carcinoma

被引:20
作者
Sewell, Duane A. [1 ]
Yuan, Chao-Xing
Robertson, Erle
机构
[1] Univ Penn, Sch Med, Dept Otorhinolaryngol, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Microbiol, Abramson Comprehens Canc Ctr,Tumor Virol Program, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Proteom Core Facil, Philadelphia, PA 19104 USA
来源
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES | 2007年 / 69卷 / 02期
关键词
proteomics; biomarkers; larynx; carcinoma;
D O I
10.1159/000097406
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Laryngeal cancer remains a worldwide health problem. The identification of biomarkers unique to laryngeal cancer may provide new insights into its pathogenesis, as well as provide potential targets for novel therapies and early detection. In order to identify potential biomarkers, we performed a proteomic analysis of laryngeal cancer specimens. Using two-dimensional differential in-gel electrophoresis and mass spectroscopy, protein expression profiles from two laryngeal carcinoma specimens and corresponding adjacent normal tissue were analyzed. The results of our analysis showed that the expression of a number of proteins was significantly altered in the tumor specimens when compared to matched normal controls. The differentially expressed proteins were identified, and they included stratifin, S100 calcium-binding protein A9, p21-ARC, stathmin, and enolase. With these findings, we have identified potential biomarkers which may contribute to the pathogenesis of laryngeal carcinoma, and which may be suitable as targets for novel therapeutic and/or diagnostic modalities. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 25 条
[1]   Clinical cancer proteomics: Promises and pitfalls [J].
Alaiya, A ;
Al-Mohanna, M ;
Linder, S .
JOURNAL OF PROTEOME RESEARCH, 2005, 4 (04) :1213-1222
[2]   Molecular markers in laryngeal squamous cell carcinoma: Towards an integrated clinicobiological approach [J].
Almadori, G ;
Bussu, F ;
Cadoni, G ;
Galli, J ;
Paludetti, G ;
Maurizi, M .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (05) :683-693
[3]   Total laryngectomy and postoperative radiotherapy for T4 laryngeal cancer: A 14-year review [J].
Ampil, FL ;
Nathan, CAO ;
Caldito, G ;
Lian, TF ;
Aarstad, RF ;
Krishnamsetty, RM .
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2004, 25 (02) :88-93
[4]   EpCAM - A new therapeutic target for an old cancer antigen [J].
Armstrong, A ;
Eck, SL .
CANCER BIOLOGY & THERAPY, 2003, 2 (04) :320-325
[5]   p27Kip1-stathmin interaction influences sarcoma cell migration and invasion [J].
Baldassarre, G ;
Belletti, B ;
Nicoloso, MS ;
Schiappacassi, M ;
Vecchione, A ;
Spessotto, P ;
Morrione, A ;
Canzonieri, V ;
Colombatti, A .
CANCER CELL, 2005, 7 (01) :51-63
[6]   Intracellular and extracellular roles of s100 proteins [J].
Donato, R .
MICROSCOPY RESEARCH AND TECHNIQUE, 2003, 60 (06) :540-551
[7]   ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor:: relationship with Myc promoter-binding protein 1 (MBP-1) [J].
Feo, S ;
Arcuri, D ;
Piddini, E ;
Passantino, R ;
Giallongo, A .
FEBS LETTERS, 2000, 473 (01) :47-52
[8]   c-myc promoter-binding protein 1 (MBP-1) regulates prostate cancer cell growth by inhibiting MAPK pathway [J].
Ghosh, AK ;
Steele, R ;
Ray, RB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (14) :14325-14330
[9]   Stathmin expression modulates migratory properties of GN-11 neurons in vitro [J].
Giampietro, C ;
Luzzati, F ;
Gambarotta, G ;
Giacobini, P ;
Boda, E ;
Fasolo, A ;
Perroteau, I .
ENDOCRINOLOGY, 2005, 146 (04) :1825-1834
[10]   14-3-3σ is a p53-regulated inhibitor of G2/M progression [J].
Hermeking, H ;
Lengauer, C ;
Polyak, K ;
He, TC ;
Zhang, L ;
Thiagalingam, S ;
Kinzler, KW ;
Vogelstein, B .
MOLECULAR CELL, 1997, 1 (01) :3-11